Please login to read the full article.
Scrip Regulatory Affairs
New bills in US House, Senate aim to streamline FDA device reviews
20 October 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US lawmaker seeks to streamline FDA's medical device approval process
- US FDA action on drug shortages yields results, agency improves user fee goals
- Will accelerated approval, antibiotic add-ons bog down PDUFA in US?
- US FDA's de novo proposal will not result in significant time saving, says medtech association
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
